A

AGILENT TECHNOLOGIES INC

Healthcare | Large Cap

$1.64

EPS Forecast

$1,871

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-01-31

Agilent's Q4 Earnings: A Solid Performance with a Bright Outlook

By Your Finance Writer

Agilent Technologies, Inc. (NYSE: A) has just released its fourth-quarter financial results for fiscal year 2025, and the numbers are impressive enough to make even the most stoic analyst crack a smile. With a revenue of $1.86 billion, the company not only exceeded its revenue forecast but also showcased a growth of 9.4% year-over-year. For those keeping score at home, that’s a solid earnings surprise that puts Agilent in a favorable position as we head into the new fiscal year.

EPS Results: A Positive Trend

Agilent's earnings per share (EPS) came in at $1.53, marking a 25% increase from the same quarter last year. This performance not only surpassed the EPS consensus but also reflects a robust operational strategy that seems to be paying off. On the non-GAAP front, the company reported an EPS of $1.59, which is up 9% from Q4 2024. With these figures, Agilent is demonstrating a commendable ability to maintain profitability while navigating the complexities of the market.

A Look at Full-Year Performance

For the full fiscal year 2025, Agilent reported a total revenue of $6.95 billion, which is a 6.7% increase on a reported basis and 4.9% on a core basis compared to fiscal year 2024. GAAP net income reached $1.303 billion, translating to an EPS of $4.57—up 3% year-over-year. These numbers indicate that Agilent isn’t just a flash in the pan; it’s building a sustainable growth model that could bode well for its future.

Guiding for the Future

Looking ahead, Agilent is optimistic about fiscal year 2026, projecting revenue in the range of $7.3 billion to $7.4 billion. This suggests a growth trajectory of 5% to 7% on a reported basis, which would be quite the feat in a competitive market. Additionally, the company is forecasting non-GAAP EPS between $5.86 and $6.00, hinting at a continued focus on profitability. For the first quarter of 2026, revenue guidance is set between $1.79 billion and $1.82 billion, indicating a solid start to the year.

Sector Implications

Agilent’s performance not only reflects its internal capabilities but also sets a tone for its peers in the tech and life sciences sectors. As companies navigate supply chain issues and fluctuating demand, Agilent’s results might serve as a benchmark for what investors can expect elsewhere. The ability to exceed revenue forecasts and maintain strong EPS figures could signal a broader trend of resilience within the industry, which is a welcome sight for investors looking for stability.

In conclusion, Agilent's fourth-quarter results and positive guidance for the upcoming year position the company as a strong contender in its field. As it continues to innovate and drive growth, stakeholders will be watching closely to see how these earnings translate into long-term value.